Reduction of Purkinje Cell Pathology in SCA1 Transgenic Mice by p53 Deletion

Author： Shahbazian M.D. Orr H.T. Zoghbi H.Y.

Publisher： Elsevier

ISSN： 0969-9961

Source： Neurobiology of Disease, Vol.8, Iss.6, 2001-12, pp. : 974-981

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amino Acids in a Region of Ataxin-1 Outside of the Polyglutamine Tract Influence the Course of Disease in SCA1 Transgenic Mice

By Skinner P.J. Vierra-Green C.A. Emamian E. Zoghbi H.Y. Orr H.T.

NeuroMolecular Medicine, Vol. 1, Iss. 1, 2002-03 ,pp. : 33-42

Humana Press, Inc

Access to resources Recommend Favorite

α-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice

By Shirakashi Yoshitomo Kawamoto Yasuhiro Tomimoto Hidekazu Takahashi Ryosuke Ihara Masafumi

Acta Neuropathologica, Vol. 112, Iss. 6, 2006-12 ,pp. : 681-689

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of Autophagy via p53-Mediated Disruption of ULK1 in a SCA7 Polyglutamine Disease Model

By Yu Xin Muñoz-Alarcón Andrés Ajayi Abiodun Webling Kristin Steinhof Anne Langel Ülo Ström Anna-Lena

Journal of Molecular Neuroscience, Vol. 50, Iss. 3, 2013-07 ,pp. : 586-599

Humana Press, Inc

Access to resources Recommend Favorite

Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice

By Bannerman P. G.

Brain, Vol. 128, Iss. 8, 2005-08 ,pp. : 1877-1886

Oxford University Press

Access to resources Recommend Favorite

The Effects of Long-Term Treatment with Metrifonate, a Cholinesterase Inhibitor, on Cholinergic Activity, Amyloid Pathology, and Cognitive Function in APP and PS1 Doubly Transgenic Mice

By Liu L. Ikonen S. Heikkinen T. Tapiola T. van Groen T. Tanila H.

Experimental Neurology, Vol. 173, Iss. 2, 2002-02 ,pp. : 196-204

Elsevier

Access to resources Recommend Favorite